Pacira Pharmaceuticals
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Pacira Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count).
Pacira Pharmaceuticals: 88 sponsored US clinical trials, 5 recruiting.
Pacira Pharmaceuticals sponsors 88 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 65 completed. 38 of these trials are in Phase 3-4 (later-stage) and 35 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteoarthritis of the Knee, with 4 trials.
Top-decile sponsor footprint
Pacira Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#265 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
65 of 82 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
88 total, page 2 of 2
Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles
NCT01984619
Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles
NCT01950065
EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries
NCT01919190
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
NCT01863901
A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device
NCT01801826
Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy
NCT01802411
Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device
NCT01808742
Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball
NCT02142829
Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device
NCT01753778
Study Evaluating the Treatment of Occipital Neuralgia
NCT01753765
Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty
NCT01683071
A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device
NCT01704157
Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects
NCT01681745
Study of FX006 in Patients With Osteoarthritis of the Knee
NCT01487161
A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302
NCT01507233
Study of EXPAREL in Patients Undergoing Breast Augmentation
NCT01582490
EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair
NCT01801124
TAP-patients With Robotic Assisted Lap Prostatectomy
NCT01582477
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501
NCT01509638
A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301
NCT01507220
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504
NCT01509807
Adult Patients Undergoing Open Colectomy MA402S23B303
NCT01507246
A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy
NCT02058290
A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines
NCT01447342
Cryo-Touch III Refinement Study Investigational Plan
NCT01379365
Cryo-Touch II for the Treatment of Wrinkles
NCT01167140
Study of Postoperative Analgesia in Bunionectomy
NCT00890682
Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation
NCT00842062
Dose Finding Posterolateral Thoracotomy Study
NCT00807209
Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation
NCT00813111
Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers
NCT00806806
A Phase 3 Study to Evaluate the Safety and Efficacy of SKY0402 in Subjects Undergoing Total Knee Arthroplasty
NCT00745290
Study to Evaluate Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
NCT00744848
Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty
NCT01206608
Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy
NCT00529126
Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty
NCT00485693
Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair
NCT00485433
DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
NCT00029523
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 22 |
| Phase 3 | 17 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the Pacira Pharmaceuticals pipeline
5 recruiting of 88 indexed (6% open); 65 completed (74%).
Phase mix: 38 late (III/IV) vs 35 early (I/II) (balanced across stages).
Top condition: Osteoarthritis of the Knee (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Pacira Pharmaceuticals: open-pipeline peers nationwide
Peers matched on 88 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
Pacira Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 88 trials (± recruiting share)
- AbbVie (prior sponsor, Abbott) · 88 trials · 0% recruiting
- University of Medicine and Dentistry of New Jersey · 88 trials · 0% recruiting
- Abbott Nutrition · 89 trials · 1% recruiting
- Florida International University · 89 trials · 20% recruiting
Sponsors near 6% open enrollment (± trial volume)
- Pfizer · 6% recruiting · 1,845 trials
- Boston College · 6% recruiting · 18 trials
- CytoDyn · 6% recruiting · 18 trials
- Dendreon · 6% recruiting · 18 trials
Related
What to do with this Pacira Pharmaceuticals page
88 registered trials is a research-attention snapshot, not an endorsement of Pacira Pharmaceuticals or any single study.
- 5 of Pacira Pharmaceuticals's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Osteoarthritis of the Knee is the condition Pacira Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteoarthritis of the Knee trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pacira Pharmaceuticals pipeline card: 88 registered trials from official public datasets.Report a data error.